D-0430-2019 Class II Terminated
FDA drug recall D-0430-2019 was initiated by Advanced Pharma Inc. on Jan 15, 2019 and is designated Class II. Reason for recall: Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL) The recall status is terminated (terminated May 1, 2019). Affected quantity: 160 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 30, 2019
- Initiation Date
- Jan 15, 2019
- Termination Date
- May 1, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 160 syringes
Product description
HEPERAIN 50 mg/50 mL (1mg/mL) Injectable Solution, Heparin Sodium 0.45% Sodium Chloride QS Heparin 50 Units 50 mL, Sterile single use syringe, Avella of Houston an FDA Registered 503B Outsourcing Facility 9265 Kirby Dr. Houston, TX 77054 (877) 794-0404 ---- NDC: 42852-725-65
Reason for recall
Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)
Distribution pattern
TX, WA
Code information
Lot: 12/19/18 0242 72565S BUD: 3/31/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0430-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026